Dual Action of n-Butanol on Neuronal Nicotinic α4β2 Acetylcholine Receptors

  1. Yi Zuo,
  2. Jay Z. Yeh and
  3. Toshio Narahashi
  1. Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Medical School, Chicago, Illinois
  1. Dr. Toshio Narahashi, Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Medical School, 303 E. Chicago Ave., Chicago, IL 60611-3008. E-mail: tna597{at}northwestern.edu

Abstract

n-Alcohols exert a dual action on neuronal nicotinic acetylcholine (ACh) receptors with short-chain alcohols exhibiting potentiating action and long-chain alcohols exhibiting inhibitory action. n-Butanol lies at the transition point from potentiation to inhibition. To elucidate the mechanism of dual action of alcohols, the effects of n-butanol on the human α4β2 ACh receptors expressed in the HEK293 cell line were analyzed in detail by the whole-cell patch-clamp technique. Prolonged applications of n-butanol evoked small currents with an EC50 value of 230 ± 90 mM and a Hill coefficient of 1.8 ± 0.4. This current was blocked by either the ACh channel blocker mecamylamine or the receptor blocker dihydro-β-erythroidine, indicating that butanol activated receptors as a partial agonist. As expected from its partial agonist action, n-butanol also modulated ACh-induced currents in a concentration-dependent manner. Butanol at 300 mM potentiated currents induced by low concentrations of ACh (≤30 μM), while inhibiting the currents induced by high concentrations of ACh (100–3000 μM). In addition, butanol at a low concentration (10 mM) suppressed the currents evoked by 10 to 3000 μM ACh, a result consistent with a channel-blocking action. Most features of n-butanol effects were satisfactorily simulated by a model in which butanol acts as a partial agonist and as a channel blocker.

Footnotes

  • This work was supported by National Institutes of Health Grant AA07836.

  • DOI: 10.1124/jpet.102.044537

  • Abbreviations:
    nAChR
    nicotinic acetylcholine receptor
    EPC
    end-plated current
    ACh
    acetylcholine
    nnAChR
    neuronal nAChR
    HEK
    human embryonic kidney
    DHβE
    dihydro-β-erythroidine
    • Received September 18, 2002.
    • Accepted November 26, 2002.
« Previous | Next Article »Table of Contents